Invention Grant
- Patent Title: Replication conditional virus that specifically kills senescent cells
-
Application No.: US16029244Application Date: 2018-07-06
-
Publication No.: US10378002B2Publication Date: 2019-08-13
- Inventor: Serge Lichtsteiner , Nathaniel David
- Applicant: Unity Biotechnology, Inc. , Kythera Biopharmaceuticals, Inc.
- Applicant Address: US CA Brisbane US CA Calabasas
- Assignee: Unity Biotechnology, Inc.,Kythera Biopharmaceuticals, Inc.
- Current Assignee: Unity Biotechnology, Inc.,Kythera Biopharmaceuticals, Inc.
- Current Assignee Address: US CA Brisbane US CA Calabasas
- Agency: Wilson Sonsini Goodrich & Rosati
- Agent Michael Schiff; Janet Martineau
- Main IPC: C12N9/50
- IPC: C12N9/50 ; C12N15/85 ; A61K38/48

Abstract:
Polypeptides, viruses, methods and compositions provided herein are useful for the selective elimination of senescent cells. Method aspects include methods for inducing apoptosis in a senescent cell comprising administering to the cell a polynucleotide, virus, host cell, or pharmaceutical composition described herein. Other methods include expressing a pro-apoptotic gene in a senescent cell comprising administering to the cell the polynucleotide, virus, or pharmaceutical composition as described herein.
Public/Granted literature
- US20190136215A1 Replication Conditional Virus that Specifically Kills Senescent Cells Public/Granted day:2019-05-09
Information query